If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

  • 5727 Citations
  • 31 h-Index
  • 128 Article
  • 2 Review article
Filter
Article
Article
3 Citations (Scopus)

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Györke, T., Kollár, A., Bottlik, G., Szepesi, Á., Bodó, I., Masszi, T., Bérczi, V. & Garai, I., ápr. 2011, In : International Journal of Hematology. 93, 4, p. 545-550 6 p.

Research output: Article

Hodgkin Disease
Lymph Nodes
Biopsy
Drug Therapy
Minimally Invasive Surgical Procedures
59 Citations (Scopus)

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

Ludwig, H., Viterbo, L., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Ricci, D., Cakana, A., Enny, C., Feng, H., Van De Velde, H. & Harousseau, J. L., jan. 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 247-255 9 p.

Research output: Article

Thalidomide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Stem Cell Transplantation

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients

Lovas, S., Varga, G., Farkas, P., Masszi, T., Wohner, N., Bereczki, Á., Adamkovich, N., Borbényi, Z., Szomor, Á., Alizadeh, H., Szaleczky, E., Wolf, K., Schneider, T., Plander, M., Szendrei, T., Csacsovszki, O., Csukly, Z., Rajnics, P., Egyed, M., Nagy, Z. & 4 others, Rejtő, L., Illés, A., Mikala, G. & Váróczy, L., jan. 1 2019, In : International Journal of Hematology.

Research output: Article

Multiple Myeloma
Safety
Disease-Free Survival
Kidney
Therapeutics
4 Citations (Scopus)

Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Balassa, K., Krahling, T., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Torbagyi, E., Gopcsa, L., Lengyel, L., Barta, A., Varga, G., Tordai, A., Masszi, T. & Andrikovics, H., júl. 7 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Article

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Haplotypes
Tissue Donors
Cytokines
37 Citations (Scopus)
Drug Combinations
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Transplants
Mitobronitol
Busulfan
13 Citations (Scopus)

Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia

Barta, A., Dénes, R., Masszi, T., Reményi, P., Bátai, Á., Torbágyi, É., Sipos, A., Lengyel, L., Jakab, K., Gyódi, É., Réti, M., Földi, J., Páldi-Haris, P., Avalos, M., Pálóczi, K., Fekete, S., Török, J., Hoffer, I., Jakab, J., Váradi, G. & 2 others, Kelemen, E. & Petrányi, G., 2001, In : Acta Haematologica. 105, 2, p. 64-70 7 p.

Research output: Article

Mitobronitol
Homologous Transplantation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Bone Marrow Transplantation
Transplants
1 Citation (Scopus)

Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor

Morris, C., Chabannon, C., Masszi, T., Russell, N., Nahi, H., Kobbe, G., Krejci, M., Auner, H. W., Pohlreich, D., Hayden, P., Basak, G. W., Lenhoff, S., Schaap, N., van Biezen, A., Knol, C., Iacobelli, S., Liu, Q., Celanovic, M., Garderet, L. & Kröger, N., jan. 1 2019, (Accepted/In press) In : Bone Marrow Transplantation.

Research output: Article

Open Access
Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Registries
Disease-Free Survival
7 Citations (Scopus)

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the european group for blood and marrow transplantation

Cesaro, S., Marsh, J., Tridello, G., Rovò, A., Maury, S., Montante, B., Masszi, T., Van Lint, M. T., Afanasyev, B., Iriondo Atienza, A., Bierings, M., Carbone, C., Doubek, M., Lanino, E., Sarhan, M., Risitano, A., Steinerova, K., Wahlin, A., Pegoraro, A. & Passweg, J., júl. 2010, In : Acta Haematologica. 124, 1, p. 19-22 4 p.

Research output: Article

Aplastic Anemia
Blood Group Antigens
Autoimmune Diseases
Registries
Transplantation
94 Citations (Scopus)

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., Blaise, D., Ciceri, F., Corbacioglu, S., Dalle, J. H., Dignan, F., Fukuda, T., Huynh, A., Masszi, T., Michallet, M., Nagler, A. & 12 others, NiChonghaile, M., Okamoto, S., Pagliuca, A., Peters, C., Petersen, F. B., Richardson, P. G., Ruutu, T., Savani, B. N., Wallhult, E., Yakoub-Agha, I., Duarte, R. F. & Carreras, E., máj. 16 2016, (Accepted/In press) In : Bone Marrow Transplantation.

Research output: Article

Hepatic Veno-Occlusive Disease
Transplantation
Bone Marrow
Cell Transplantation
Bone Marrow Transplantation
71 Citations (Scopus)

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Verstovsek, S., Vannucchi, A. M., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Kirito, K., Besses, C., Hino, M., Moiraghi, B., Miller, C. B., Cazzola, M., Rosti, V., Blau, I., Mesa, R., Jones, M. M., Zhen, H. & 4 others, Li, J., Francillard, N., Habr, D. & Kiladjian, J. J., 2016, In : Haematologica. 101, 7, p. 821-829 9 p.

Research output: Article

Polycythemia Vera
Spleen
Therapeutics
Hydroxyurea
Hematocrit
269 Citations (Scopus)

Ruxolitinib versus standard therapy for the treatment of polycythemia vera

Vannucchi, A. M., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Mesa, R., He, S., Jones, M. M., Garrett, W., Li, J., Pirron, U., Habr, D. & Verstovsek, S., jan. 1 2015, In : New England Journal of Medicine. 372, 5, p. 426-435 10 p.

Research output: Article

Polycythemia Vera
Hydroxyurea
Hematocrit
Therapeutics
Janus Kinase 1
93 Citations (Scopus)

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial

Pardanani, A., Harrison, C., Cortes, J. E., Cervantes, F., Mesa, R. A., Milligan, D., Masszi, T., Mishchenko, E., Jourdan, E., Vannucchi, A. M., Drummond, M. W., Jurgutis, M., Kuliczkowski, K., Gheorghita, E., Passamonti, F., Neumann, F., Patki, A., Gao, G. & Tefferi, A., aug. 1 2015, In : JAMA oncology. 1, 5, p. 643-651 9 p.

Research output: Article

Primary Myelofibrosis
Randomized Controlled Trials
Safety
Essential Thrombocythemia
Polycythemia Vera
6 Citations (Scopus)

Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration

Marschalkó, M., Eros, N., Holló, P., Hársing, J., Bottlik, G., Bátai, Á., Csukly, Z., Masszi, T., Szentirmai, Z., Fodor, J., Kárpáti, S., Matolcsy, A. & Csomor, J., okt. 2010, In : American Journal of Dermatopathology. 32, 7, p. 708-712 5 p.

Research output: Article

Lymphomatoid Papulosis
Anaplastic Large-Cell Lymphoma
Primary Cutaneous Anaplastic Large Cell Lymphoma
Lymph Nodes
T-Cell Receptor gamma Genes
16 Citations (Scopus)

Serum α2-HS glycoprotein concentration in patients with hematological malignancies - A follow-up study

Kalabay, L., Cseh, K., Benedek, S., Fekete, S., Masszi, T., Herjeczki, K., Pozsonyi, T., Jakab, L. & Jakab, L., nov. 1991, In : Annals of Hematology. 63, 5, p. 264-269 6 p.

Research output: Article

Hematologic Neoplasms
Glycoproteins
Serum
Cytostatic Agents
Leukemia, Myelomonocytic, Chronic
12 Citations (Scopus)

Serum β2-microglobulin measured by immunonephelometry: Expression patterns and reference intervals in healthy adults

Mátrai, Z., Németh, J., Miklós, K., Szabó, Z. & Masszi, T., máj. 1 2009, In : Clinical Chemistry and Laboratory Medicine. 47, 5, p. 585-589 5 p.

Research output: Article

Population Characteristics
Blood Donors
Serum
Blood
Statistics

Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Szilvasi, A., Bors, A., Kiss, K. P., Rajczy, K., Inotai, D., Torbagyi, E., Lengyel, L., Barta, A., Gopcsa, L., Tordai, A. & Masszi, T., jan. 1 2018, In : Human Immunology. 79, 1, p. 13-19 7 p.

Research output: Article

Hematopoietic Stem Cell Transplantation
Tissue Donors
Survival
Neoplasms
Transplantation
135 Citations (Scopus)

Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., Blaise, D., Ciceri, F., Corbacioglu, S., Dalle, J. H., Duarte, R. F., Fukuda, T., Huynh, A., Masszi, T., Michallet, M., Nagler, A. & 10 others, Nichonghaile, M., Pagluica, T., Peters, C., Petersen, F. B., Richardson, P. G., Ruutu, T., Savani, B. N., Wallhult, E., Yakoub-Agha, I. & Carreras, E., jún. 4 2015, In : Bone Marrow Transplantation. 50, 6, p. 781-789 9 p.

Research output: Article

Hepatic Veno-Occlusive Disease
Transplantation
Bone Marrow
Biomarkers
Prospective Studies

Skin-homing CD8+ T cells preferentially express GPI-anchored peptidase inhibitor 16, an inhibitor of cathepsin K

Lupsa, N., Érsek, B., Horváth, A., Bencsik, A., Lajkó, E., Silló, P., Oszvald, Á., Wiener, Z., Reményi, P., Mikala, G., Masszi, T., Búzás, E. & Pós, Z., dec. 1 2018, In : European Journal of Immunology. 48, 12, p. 1944-1957 14 p.

Research output: Article

Cathepsin K
Protease Inhibitors
Skin
Graft vs Host Disease
Granzymes
5 Citations (Scopus)
caspofungin
Aspergillus flavus
Salvage Therapy
Homologous Transplantation
Bone Marrow Transplantation
5 Citations (Scopus)
Treatment Failure
Multiple Myeloma
Bone Marrow Transplantation
Renal Insufficiency
Kidney
167 Citations (Scopus)

Superiority of the triple combination of bortezomib-thalidomide- dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: The MMVAR/IFM 2005-04 randomized phase III trial from the chronic leukemia working party of the European Group for blood and marrow transplantation

Garderet, L., Iacobelli, S., Moreau, P., Dib, M., Lafon, I., Niederwieser, D., Masszi, T., Fontan, J., Michallet, M., Gratwohl, A., Milone, G., Doyen, C., Pegourie, B., Hajek, R., Casassus, P., Kolb, B., Chaleteix, C., Hertenstein, B., Onida, F., Ludwig, H. & 10 others, Ketterer, N., Koenecke, C., Van Os, M., Mohty, M., Cakana, A., Gorin, N. C., De Witte, T., Harousseau, J. L., Morris, C. & Gahrton, G., júl. 10 2012, In : Journal of Clinical Oncology. 30, 20, p. 2475-2482 8 p.

Research output: Article

Thalidomide
Autologous Transplantation
Blood Group Antigens
Multiple Myeloma
Dexamethasone
78 Citations (Scopus)

Syngeneic transplantation in multiple myeloma - A case-matched comparison with autologous and allogeneic transplantation

Gahrton, G., Svensson, H., Björkstrand, B., Apperley, J., Carlson, K., Cavo, M., Ferrant, A., Fouillard, L., Gratecos, N., Gratwohl, A., Guilhot, F., Lambertenghi Deliliers, G., Ljungman, P., Masszi, T., Milligan, D. W., Powles, R. L., Reiffers, J., Samson, J. D., Stoppa, A. M., Vernant, J. P. & 2 others, Volin, L. & Wallvik, J., 1999, In : Bone Marrow Transplantation. 24, 7, p. 741-745 5 p.

Research output: Article

Isogeneic Transplantation
Autologous Transplantation
Homologous Transplantation
Multiple Myeloma
Transplants
7 Citations (Scopus)

Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation [4]

Masszi, T., Farkas, A., Remenyi, P., Lueff, S., Batai, A., Krivan, G., Kemény, L., Dobozy, A. & Reti, M., nov. 2005, In : Dermatology. 212, 1, p. 88-89 2 p.

Research output: Article

Remission Induction
Autologous Transplantation
Immune System Diseases
Homologous Transplantation
Bone Marrow Transplantation

The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma

Kiss, K. P., Varga, G., Mikala, G., Balassa, K., Bors, A., Kovy, P., Meggyesi, N., Kozma, A., Csacsovszki, O., Remenyi, P., Valyi-Nagy, I., Tordai, A., Masszi, T. & Andrikovics, H., márc. 4 2018, In : Leukemia and Lymphoma. 59, 3, p. 710-716 7 p.

Research output: Article

Clinical Protocols
Multiple Myeloma
Oncogenes
Proteasome Inhibitors
Genes
11 Citations (Scopus)

The potential role of HLA-DRB1∗11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Szilvasi, A., Rajczy, K., Inotai, D., Gopcsa, L., Lengyel, L., Barta, A., Reti, M., Tordai, A. & Masszi, T., okt. 1 2015, In : Bone Marrow Transplantation. 50, 10, p. 1321-1325 5 p.

Research output: Article

Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
19 Citations (Scopus)

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

Koszarska, M., Bors, A., Feczko, A., Meggyesi, N., Batai, A., Csomor, J., Adam, E., Kozma, A., Orban, T. I., Lovas, N., Sipos, A., Karaszi, E., Dolgos, J., Fekete, S., Reichardt, J., Lehoczky, E., Masszi, T., Tordai, A. & Andrikovics, H., máj. 2013, In : Leukemia and Lymphoma. 54, 5, p. 1028-1035 8 p.

Research output: Article

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Mutation
Survival
Platelet Count
2 Citations (Scopus)

Uj, sugárzásmentes csontvelö-transzplantációs kondicionáló kezelés dibróm-mannitollal krónikus myeloid leukaemiában.

Kelemen, E., Dénes, R., Barta, A., Masszi, T., Reményi, P., Pálóczi, K., Bátai, A., Torbágyo, E., Sipos, A., Lengyel, L., Jakab, K., Gyódi, E., Réti, M., Földi, J., Páldi-Haris, P., Manuel, A., Fekete, S., Török, J., Hoffer, I., Jakab, J. & 2 others, Váradi, G. & Petrányi, G., aug. 23 1998, In : Orvosi Hetilap. 139, 34

Research output: Article

Mannitol
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Bone Marrow Transplantation
Radiation
Cyclophosphamide
126 Citations (Scopus)

VMP (Bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III VISTA study

Dimopoulos, M. A., Richardson, P. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kastritis, E., Kropff, M., Petrucci, M. T., Delforge, M., Alexeeva, J., Schots, R., Masszi, T., Mateos, M. V., Deraedt, W., Liu, K., Cakana, A., Van De Velde, H. & San Miguel, J. F., dec. 20 2009, In : Journal of Clinical Oncology. 27, 36, p. 6086-6093 8 p.

Research output: Article

Melphalan
Prednisone
Multiple Myeloma
Cohort Studies
Kidney